NPS Pharma CEO: Natpara will have greater potential than ...

CNBC Videos
Francois Nader, NPS Pharmaceuticals president & CEO, discusses its lead product Gattex for "short bowel syndrome," the potential for Natpara and the solid performance of its stock.
View Comments (0)